Rupatadine

CAS 158876-82-5 10 current recordsSmall Molecule

Who holds supplier records for Rupatadine? 10 organisations hold a current record for Rupatadine: an active US FDA Type II Drug Master File or a CEP. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7) and France (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rupatadine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rupatadine

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rupatadine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7France1Country not recorded for 2
Need Rupatadine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Rupatadine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
FDC LIMITED MumbaiIN
CEP 2024-018 - Rev 01
Rupatadine fumarate
May 2026—
TYCHE INDUSTRIES LIMITED HyderabadIN
CEP 2018-213 - Rev 02
Rupatadine fumarate
Mar 2026—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2025-532 - Rev 00
Rupatadine fumarate
Jan 2026Inspected Mar 2026
Spain
TAGOOR LABORATORIES PRIVATE LIMITED VisakhapatnamIN
CEP 2025-343 - Rev 00
Rupatadine fumarate
Jan 2026—
URQUIMA S.A. Palau-solità i PlegamansES
CEP 2017-202 - Rev 01
Rupatadine fumarate
Jan 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2024-294 - Rev 01
Rupatadine fumarate
Nov 2025—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
CEP 2018-161 - Rev 03
Rupatadine fumarate, Micronised and Non-micronised
Apr 2025—
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2018-180 - Rev 03
Rupatadine fumarate
Apr 2025—
PHARMASYNTHESE Saint Pierre Les ElbeufFR
CEP 2021-095 - Rev 00
Rupatadine fumarate, Micronised, non-micronised
Jul 2024Inspected Mar 2025
France
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. HyderabadIN
CEP 2023-016 - Rev 00
Rupatadine fumarate
Jul 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Overview

Rupatadine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL91397).

Chemical identity

IUPAC name
13-chloro-2-[1-[(5-methyl-3-pyridinyl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
Canonical SMILES
CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2
InChIKey
WUZYKBABMWJHDL-UHFFFAOYSA-N
Synonyms
Rupatadina, Rupatadine, UR-12592, Rinialer, rupatadinum, RefChem:883977, R06AX28, Alergoliber, Pafinur, Rupax, Rupatadine [INN], Alergoliber; Pafinur; Rinialer; Rupax

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rupatadine?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Rupatadine: MOREPEN LABORATORIES LTD (India), URQUIMA SA, VASUDHA PHARMA CHEM LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Cadila Pharmaceuticals Limited (India), Hetero Labs Limited (India), Tagoor Laboratories Pvt. Ltd (India) and TYCHE INDUSTRIES LTD, and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rupatadine Drug Master Files are active?

MOREPEN LABORATORIES LTD (DMF 43083), URQUIMA SA (DMF 36047) and VASUDHA PHARMA CHEM LTD (DMF 38451). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Rupatadine have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Rupatadine on the EDQM register, including FDC LIMITED Mumbai (IN), TYCHE INDUSTRIES LIMITED Hyderabad (IN), MOREPEN LABORATORIES LIMITED Baddi (IN), TAGOOR LABORATORIES PRIVATE LIMITED Visakhapatnam (IN), URQUIMA S.A. Palau-solità i Plegamans (ES) and HETERO LABS LIMITED Hyderabad (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rupatadine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rupatadine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.